Stock Taper
ADVB
ADVANCED BIOMED INC. COMMON STOCK
NASDAQ
$9.70
▲ UP 1.36% (0.13)

KEY STATISTICS

Market Cap$13.41 M
52w High$24.23
52w Low$3.61
Dividend Yield
Frequency
P/E-88.18
Volume275.18K
Shares Out.1.38M

COMPANY

LEADERSHIP

Xiaomin Chen
CHIEF EXECUTIVE
Xiaomin Chen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 6, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
31

SPLIT RECORD

DATETYPERATIO
2026-02-20Reverse1:20

PRICE

$9.70 ▲ UP 1.36% (+$0.13)
OVERLAYS
$9.20$9.40$9.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM9.70

About Advanced Biomed Inc. Common Stock

https://www.advanbiomed.com ↗

Advanced Biomed Inc. develops microfluidic biochips and immunochromogenic kits for precision oncology detection, diagnosis, and treatment, primarily serving cancer patients in Taiwan and China.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT ADVANCED BIOMED INC. COMMON STOCK IS KNOWN FOR

A+PerfusC 3D cell culture platform
A+PerfusC 3D cell culture platform

An integrated perfusion 3D cell culture system that mimics human physiology to improve drug discovery and precision medicine by enabling more accurate growth of circulating tumor cells compared to traditional 2D models.

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

10 PERCENT OWNER
Pau Hung To
Sale · 100.0K shares
2026-07-27
10 PERCENT OWNER
Pau Hung To
Sale · 76.2K shares
2026-07-27

SECTORS PEERS

PEERPRICE
MRKR$1.37COMPARE
TRIB$9.68COMPARE
GELS$0.56COMPARE
MBIO$0.54COMPARE
BGLC$1.55COMPARE
XAIR$4.48COMPARE
TNON$5.00COMPARE
RDGT$1.00COMPARE